H Moch
PD-L1 is a positive prognostic factor in squamous cell carcinoma of the nasal vestibule
Vital D, Holzmann D, Huber G, Moch H, Morand G, Ikenberg K. PD-L1 is a positive prognostic factor in squamous cell carcinoma of the nasal vestibule. Rhinology 2018
Feb 21, 2018PD-L1 is a positive prognostic factor in squamous cell carcinoma of the nasal vestibule
Feb 21, 2018Rhinology 2018
Vital D, Holzmann D, Huber Gerhard, Moch H, Morand G B, Ikenberg K
Tracking the origin of simultaneous endometrial and ovarian cancer by nextgeneration sequencing – a case report
Valtcheva N, Dedes K, Rechsteiner M, Moch H, Fink D, Bellini E, Schmidt A, Samartzis E, Noske A, Winder F, Wild P. Tracking the origin of simultaneous endometrial and ovarian cancer by nextgeneration sequencing – a case report. BMC cancer 2017; 17:66.
Jun 26, 2017Tracking the origin of simultaneous endometrial and ovarian cancer by nextgeneration sequencing – a case report
Jun 26, 2017BMC cancer 2017; 17:66
Valtcheva N, Dedes KJ, Rechsteiner M, Moch H, Fink D, Bellini E, Schmidt AM, Samartzis E, Noske A, Winder Franziska, Wild PJ
Brain metastases in gastro-oesophageal adenocarcinoma: insights into the role of the human epidermal growth factor receptor 2 (HER2)
Feilchenfeldt J, Jochum W, Shoji H, Kushima R, Wagner D, Shimada Y, Cats A, Knuth A, Moch H, Aebi S, Diebold J, Khanfir K, Varga Z, Siano M, Grabsch H, Held U, Schuknecht B, Trip A, Hamaguchi T, Gut P, Balague O, Hofer S. Brain metastases in gastro-oesophageal adenocarcinoma: insights into the role of the human epidermal growth factor receptor 2 (HER2). Br J Cancer 2015; 113:716-21.
Aug 27, 2015Brain metastases in gastro-oesophageal adenocarcinoma: insights into the role of the human epidermal growth factor receptor 2 (HER2)
Aug 27, 2015Br J Cancer 2015; 113:716-21
Feilchenfeldt J, Jochum Wolfram, Shoji H, Kushima R, Wagner D, Shimada Y, Cats A, Knuth A, Moch H, Aebi S, Diebold J, Khanfir K, Varga Z, Siano Marco, Grabsch H I, Held U, Schuknecht B, Trip A, Hamaguchi T, Gut P, Balague O, Hofer S
High sex determining region Y-box 2 expression is a negative predictor of occult lymph node metastasis in early squamous cell carcinomas of the oral cavity
Züllig L, Roessle M, Weber C, Graf N, Haerle S, Jochum W, Stöckli S, Moch H, Huber G. High sex determining region Y-box 2 expression is a negative predictor of occult lymph node metastasis in early squamous cell carcinomas of the oral cavity. Eur J Cancer 2013; 49:1915-22.
Feb 12, 2013High sex determining region Y-box 2 expression is a negative predictor of occult lymph node metastasis in early squamous cell carcinomas of the oral cavity
Feb 12, 2013Eur J Cancer 2013; 49:1915-22
Züllig L, Roessle M, Weber C, Graf N, Haerle S K, Jochum W, Stöckli Sandro, Moch H, Huber G F
First-line temozolomide combined with bevacizumab in metastatic melanoma: a multicentre phase II trial (SAKK 50/07)
von Moos R, Dummer R, Schönewolf N, Mamot C, Mjhic-Probst D, Schraml P, Moch H, Schläppi M, Cathomas R, Michielin O, Ochsenbein A, Gillessen S, Goldinger S, Simcock M, Seifert B, on behaalf of the Swiss Group for Clinical Cancer Research (SAKK). First-line temozolomide combined with bevacizumab in metastatic melanoma: a multicentre phase II trial (SAKK 50/07). Ann Oncol 2011; 23:531-6.
Apr 28, 2011First-line temozolomide combined with bevacizumab in metastatic melanoma: a multicentre phase II trial (SAKK 50/07)
Apr 28, 2011Ann Oncol 2011; 23:531-6
von Moos R, Dummer R, Schönewolf N, Mamot C, Mjhic-Probst D, Schraml P H, Moch H, Schläppi M, Cathomas R, Michielin O, Ochsenbein A, Gillessen S, Goldinger S M, Simcock M, Seifert B, on behaalf of the Swiss Group for Clinical Cancer Research (SAKK)
Sentinel lymph node biopsy is associated with improved survival compared to level I & II axillary lymph node dissection in node negative breast cancer patients
Langer I, Oertli D, Harder F, Wight E, Moch H, Viehl C, Ladewig A, Hsu-Schmitz S, Gueller U, Zuber M. Sentinel lymph node biopsy is associated with improved survival compared to level I & II axillary lymph node dissection in node negative breast cancer patients. Eur J Surg Oncol 2008; 35:805-13.
Nov 28, 2008Sentinel lymph node biopsy is associated with improved survival compared to level I & II axillary lymph node dissection in node negative breast cancer patients
Nov 28, 2008Eur J Surg Oncol 2008; 35:805-13
Langer I, Oertli D, Harder F, Wight E, Moch H, Viehl C T, Ladewig A, Hsu-Schmitz S F, Gueller Ulrich, Zuber M
MAGE-C1/CT-7 expression in plasma cell myeloma: sub-cellular localization impacts on clinical outcome
Tinguely M, Knuth A, Moch H, Probst-Hensch N, Renner C, Maurer R, Dommann-Scherrer C, Schmid U, Bittermann A, Cogliatti S, Curioni Fontecedro A, Rousson V, Korol D, Lopes B, Knights A, Jenni B, Zippelius A. MAGE-C1/CT-7 expression in plasma cell myeloma: sub-cellular localization impacts on clinical outcome. Cancer science 2008; 99:720-5.
Apr 1, 2008MAGE-C1/CT-7 expression in plasma cell myeloma: sub-cellular localization impacts on clinical outcome
Apr 1, 2008Cancer science 2008; 99:720-5
Tinguely M, Knuth A, Moch H, Probst-Hensch N M, Renner C, Maurer R, Dommann-Scherrer C, Schmid U, Bittermann A G, Cogliatti Sergio B., Curioni Fontecedro A, Rousson V, Korol D, Lopes B, Knights A, Jenni B, Zippelius A